Clinical Trial Update: A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma [Phase 1]

View source ↗

Summary

This update reports results from a Phase 1B trial evaluating the combination of trametinib and digoxin in patients with unresectable or metastatic BRAF wild-typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LANOXIN (Digoxin)
• MEKINIST (trametinib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Melanoma | Phase 1 | Status: COMPLETED